ストックスクリーナーアプリを入手
7.30
1.08%
-0.08
前日終値:
$7.38
開ける：
$7.35
24時間の取引高:
44,773
Relative Volume:
0.64
時価総額：
$424.39M
収益：
$154.57M
当期純損益:
$15.07M
株価収益率:
27.04
EPS:
0.27
ネットキャッシュフロー:
$10.92M
1週間 パフォーマンス:
+3.55%
1か月 パフォーマンス:
-6.17%
6か月 パフォーマンス:
-6.23%
1年 パフォーマンス:
+36.96%
1日の値動き範囲:
$7.15
$7.44
1週間の範囲:
$7.002
$7.85
52週間の値動き範囲:
$5.17
$9.155
Kamada Ltd Stock (KMDA) Company Profile
KMDA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.30 | 424.39M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
153.06 | 67.56B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.80 | 46.65B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.48B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.54 | 19.74B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.06 | 14.01B | 2.99B | 1.21B | 1.13B | 25.06 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | 開始されました | The Benchmark Company | Buy |
| 2024-07-03 | 開始されました | Stifel | Buy |
| 2018-02-02 | 開始されました | Chardan Capital Markets | Buy |
Kamada Ltd (KMDA) 最新ニュース
Kamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025 - MSN
Is Kamada Ltd. still worth holding after the dipRisk Management & Daily Profit Maximizing Tips - Newser
Kamada Ltd. Achieves 11% Revenue Growth, Raises EBITDA Guidance - AInvest
Kamada stock price target maintained at $15 by Benchmark on strong earnings - Investing.com
Kamada Ltd. (NASDAQ:KMDA) Q2 2025 Earnings Call Transcript - Insider Monkey
Using RSI to spot recovery in Kamada Ltd.2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser
How hedge fund analytics apply to Kamada Ltd. stockInsider Selling & Weekly Chart Analysis and Guides - Newser
How sentiment analysis helps forecast Kamada Ltd.July 2025 Volume & Free Community Consensus Stock Picks - Newser
Kamada Ltd (KMDA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Increased ... - Yahoo Finance
Kamada Ltd. Reports Strong 2025 Financial Growth - TipRanks
Kamada's Q2 2025: Tax Rate Fluctuations and Clinical Enrollment Contradictions Unveiled - AInvest
Kamada Q2 2025 Earnings Call Transcript - MarketBeat
Kamada Reports Strong Q2 Earnings, Raises Full-Year Guidance, and Secures FDA Approval for Plasma Collection Center - AInvest
Kamada Ltd Outpaces Expectations As FDA Nod Adds Fuel - Finimize
Kamada Ltd Outpaces Expectations With Strong Results And Upbeat Forecast - Finimize
Kamada Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Kamada: Q2 Earnings Snapshot - Connecticut Post
Kamada's Q2 Earnings and Strategic Growth Catalysts: A Deep Dive into a Biopharma Innovator's Scalable Model - AInvest
Will breakout in Kamada Ltd. lead to full recoveryMarket Volume Report & Weekly High Momentum Picks - Newser
Kamada Reports Strong Second Quarter and First Half 2025 - GlobeNewswire
Kamada Reports Q2 Earnings: EPS Beats Expectations, Revenue Misses - AInvest
Kamada Raises Full-Year Guidance as Plasma Therapy Sales Drive 35% Profit Growth - Stock Titan
Strategies to average down on Kamada Ltd.2025 Short Interest & Long-Term Safe Investment Plans - Newser
How to recover losses in Kamada Ltd. stockGold Moves & Daily Entry Point Alerts - Newser
Will Kamada Ltd. rebound enough to break even2025 Valuation Update & Fast Moving Stock Trade Plans - Newser
Kamada Receives FDA Approval for Houston Plasma Center - AInvest
Kamada’s Houston Plasma Center Gains FDA Approval - The Globe and Mail
Can Kamada Ltd. deliver alphaMulti-Year Breakout Candidates - metrotimes.co.kr
What makes Kamada Ltd. stock price move sharplyWeekly Stock Market Strategy Summary - Newser
Is Kamada Ltd. showing insider buyingRecession Proof Stock Watch - 뉴스임팩트
Kamada Ltd. shares fall 2.45% after-hours as Houston Center begins sales of Normal Source Plasma. - AInvest
Kamada Says Houston Center Cleared to Begin Sales of Normal Source Plasma - MarketScreener
FDA approves Kamada’s Houston plasma collection center - Investing.com
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas - GlobeNewswire
Kamada Secures FDA Approval for $10M Revenue Plasma Center, Set to Be Largest Specialty Collection Site - Stock Titan
Intrinsic Value of Kamada Ltd. Stock: Is It Undervalued or OvervaluedFree Daily Volume Spike Trading Signals - Newser
Kamada (KMDA) Expected to Announce Earnings on Wednesday - Defense World
Screener Results Flag Kamada Ltd. as OversoldWealth Building Stock Market Ideas Based on Momentum - metal.it
What recovery options are there for Kamada Ltd.Free Pattern Detection for Entry Confirmation - Newser
Is Kamada Ltd. a top pick in the sectorCompounding Growth Ideas - kangso.co.kr
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Full technical analysis of Kamada Ltd. stockProfitable Trading Blueprint with Entry Zones - Newser
Kamada Announces Q2 and H1 2025 Financial Results on August 13, 2025. - AInvest
Kamada to Announce Q2 and H1 2025 Financial Results on August 13, 2025 - AInvest
Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 - 富途牛牛
Kamada Q2 Earnings: Rare Disease Biotech Giant Reveals Latest Financial Results Next Week - Stock Titan
Alpha-1 Antitrypsin Deficiency Pipeline Assessment Report - openPR.com
What is Kamada Ltd. company’s growth strategyAccelerated earnings growth - Jammu Links News
What are analysts’ price targets for Kamada Ltd. in the next 12 monthsTremendous return on equity - Jammu Links News
What is the dividend policy of Kamada Ltd. stockBuild a diversified portfolio for steady growth - Jammu Links News
Kamada Ltd (KMDA) 財務データ
収益
当期純利益
現金流量
EPS
1.29%
1.07%
大文字化:
|
ボリューム (24 時間):